Dental Anesthesia Global Market Report 2024

The dental anesthesia market has grown strongly in recent years. It will grow from $2.2 billion in 2023 to $2.39 billion in 2024 at a compound annual growth rate (CAGR) of 8.5%. The expansion observed during the historical period can be attributed to factors such as the emphasis on patient-centered care, increased adoption of sedation dentistry, advancements driven by research and clinical studies, investment in education and training initiatives, and a heightened focus on patient comfort and safety.

The dental anesthesia market is expected to see strong growth in the next few years. It will grow to $3.18 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%. The anticipated growth in the forecast period can be attributed to factors such as an emphasis on enhanced patient experience, an increasing demand for minimally invasive procedures, the development of safer anesthetic agents, the provision of personalized anesthesia solutions, and the introduction of innovative needle-free anesthesia techniques. Major trends expected in this period include the integration of digital dentistry, the adoption of non-injectable anesthesia techniques, the implementation of technology-driven delivery systems, and a continued commitment to a patient-centered care approach.

The dental anesthesia market is anticipated to experience growth, propelled by the high prevalence of dental diseases. The prevalence of dental diseases refers to the proportion of individuals within a population affected by specific dental conditions or diseases at a given time. Dental anesthesia plays a crucial role in alleviating pain and discomfort associated with dental diseases, enabling patients to undergo procedures such as fillings, root canals, or extractions more comfortably. As the incidence of dental diseases rises globally, there is an increased demand for dental procedures, consequently driving the need for dental anesthesia. In March 2023, the World Health Organization reported that oral diseases affected approximately 3.5 billion people worldwide, with around 2 billion individuals experiencing caries in permanent teeth and approximately 514 million children suffering from caries in primary teeth. The heightened prevalence of dental diseases is a significant factor fueling the growth of the dental anesthesia market.

The growth in the number of dental practitioners is expected to contribute to the expansion of the dental anesthesia market. Dental practitioners, also known as oral health professionals, are licensed individuals providing a range of oral health care services. The increase in the number of dental practitioners leads to a rise in dental clinics, creating more opportunities for dental procedures and the administration of anesthesia. According to a report from the American Dental Association (ADA) Health Policy Institute, there were 60.8 dentists per 100,000 people in 2021, and this number is projected to increase steadily from 2025 to 2040, reaching 67 dentists per 100,000 people. The growing number of dental practitioners is a key driver behind the growth of the dental anesthesia market.

Product innovation stands out as a prominent trend gaining traction in the dental anesthesia market, with major companies actively developing new products to maintain and strengthen their market positions. An illustration of this trend is seen in the actions of Hikma Pharmaceuticals PLC, a UK-based pharmaceutical company, which introduced Bupivacaine HCl Injection in December 2021. Specifically formulated for regional and local anesthesia, this injection caters to a range of medical procedures, including surgery, dental diagnostics, therapeutic interventions, and obstetrics. Available in concentrations of 0.25%, 0.5%, and 0.75% in 10 mL and 30 mL doses, this product is designed to meet the demands of local and regional anesthesia procedures.

Major players in the dental anesthesia market are strategically opting for partnerships to address oral pain management challenges. An example of this approach is demonstrated by the collaboration between Young Innovations Inc., a US-based dental equipment and supplies manufacturing company, and Synapse Dental LLC, a US-based dental solution provider. This partnership, formed in August 2022, aims to revolutionize dental care with the introduction of the Dental Pain Eraser - an innovative electronic dental anesthesia device resembling a pen. This device offers swift relief and prevention of oral pain without the need for local anesthetic injections, gels, or medications. Through this collaboration, Young Innovations and Synapse Dental aim to provide dental professionals and patients with enhanced access to pain-free dental care, addressing common anxieties associated with dental visits.

In July 2021, Septodont, a France-based pharmaceutical and medical device company, acquired the Rodogyl dental infiltrative anesthetic brand from Sanofi. This strategic acquisition expands and diversifies Septodont's dental portfolio, enriching it with the addition of Rodogyl, a brand formerly owned by Sanofi, a France-based pharmaceutical and dental care product manufacturer, known for its expertise in anesthesia.

Major companies operating in the dental anesthesia market report are Laboratorios Inibsa S.A., Laboratorios Normon S.A., Septodont Holding, Pierre Pharma, Primex Pharmaceuticals AB, Aspen Dental Management Inc., Dentalhitec, Zeyco Inc., Centrix Inc., 3M Company, Crosstex International Inc., DMG America LLC, Cetylite Industries Inc., Henry Schein Inc., AstraZeneca PLC, Johnson & Johnson, Dentsply Sirona Inc., ICPA Health Products Ltd., Patterson Companies Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Baxter International Inc., Hospira Inc., Abbott Laboratories, Merck & Co. Inc., Pfizer Inc., GlaxoSmithKline plc, Sanofi S.A., Coast Dental Services LLC, Pacific Dental Services LLC, Heartland Dental LLC, Great Expressions Dental Centers.

North America was the largest region in the dental anesthesia market in 2023. The regions covered in the dental anesthesia market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the dental anesthesia market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The principal categories of dental anesthesia comprise local anesthesia, general anesthesia, and sedation. Local anesthesia targets a particular region of the body, and in the context of dental care, it is applied to numb specific areas such as the gums, teeth, or tongue during dental procedures. Various types of products, including lidocaine, mepivacaine, prilocaine, articaine, and others, are administered through oral, intravenous, and other routes of administration, each offering short, medium, or long-duration effects. The end-users of dental anesthesia encompass hospitals, dental clinics, and other healthcare settings.

The dental anesthesia market research report provides dental anesthesia market statistics, including dental anesthesia industry global market size, regional shares, competitors with a dental anesthesia market share, detailed dental anesthesia market segments, market trends and opportunities, and any further data you may need to thrive in the dental anesthesia industry. This dental anesthesia market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The dental anesthesia market consists of sales of bupivacaine and propofol. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.